B

에스디바이오센서

137310KOSPI

59.0 / 100

Reference Date: 2026-10-23

Financial Score22.5 / 40
News Sentiment12.5 / 25
Momentum14.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 9.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

SD Biosensor, established in 2010, specializes in in-vitro diagnostics, offering products such as STANDARD Q, STANDARD F, and STANDARD E, which are known for high sensitivity and specificity. These products are used for rapid testing of various diseases, including COVID-19, and hold significant market share globally. The in-vitro diagnostics industry plays a crucial role in disease prevention and public health, with stringent regulations in major countries.

Number of Employees

656people

Average Salary

67.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.35Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-19.49Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
18.81Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.1% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.0% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (20%)

Current 6,690Won52-week high 10,08052-week low 5,820
1-month return5.0Point

1m +8.96% (rising)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0